IINN Stock Alert: The Agreement News Sending Inspira Technologies SkyrocketingInvestorPlace • 01/31/22
Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $212 Million for Inspira Over a 7-Year Period, Subject to Regulatory ApprovalsPRNewsWire • 01/31/22
Inspira Technologies Has Listed an FDA Class I 510(k) Exempt component of the ART systemPRNewsWire • 01/28/22
Professor Daniel Brodie, the President of the International Extracorporeal Organization (ELSO) and Director of Critical Care from New-York Columbia - Presbyterian Hospital, Has Joined Inspira Technologies' Advisory BoardPRNewsWire • 01/19/22
5 Short Squeeze Candidates To Watch: Biofrontera Rejoins And Tops List, 2 New Names Enter LeaderboardBenzinga • 12/27/21
IINN Stock Alert: Why Investors Are Buzzing About Inspira Technologies as Shares Blast HigherInvestorPlace • 12/09/21
Inspira Technologies Signs Strategic Agreement with Innovimed for the Potential Deployment of 1,522 ART Systems in Poland, Czech Republic & SlovakiaPRNewsWire • 12/09/21
Inspira Technologies Files a PCT Patent Application for its Flagship ART Device and Proprietary Method of Use to Minimize the Need for Mechanical VentilationPRNewsWire • 12/08/21
Inspira Technologies: Professor Eddy Fan, Expert in Critical Care Medicine and Extracorporeal Support, Joins Inspira's Scientific Advisory BoardPRNewsWire • 11/30/21
Dr. Stephane Ledot, an Expert in Critical Care and Anesthesia, Has Joined Inspira Technologies' Scientific Advisory BoardPRNewsWire • 11/22/21
Inspira Technologies Files a PCT Patent Application for its Novel Dual Lumen Cannula Used for Blood OxygenationPRNewsWire • 11/10/21
